Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity.

Niethammer M, Tang CC, Vo A, Nguyen N, Spetsieris P, Dhawan V, Ma Y, Small M, Feigin A, During MJ, Kaplitt MG, Eidelberg D.

Sci Transl Med. 2018 Nov 28;10(469). pii: eaau0713. doi: 10.1126/scitranslmed.aau0713.

PMID:
30487248
2.

A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia.

Nazem A, Tang CC, Spetsieris P, Dresel C, Gordon ML, Diehl-Schmid J, Grimmer T, Yakushev I, Mattis PJ, Ma Y, Dhawan V, Eidelberg D.

Alzheimers Dement (Amst). 2018 Aug 29;10:583-594. doi: 10.1016/j.dadm.2018.07.009. eCollection 2018.

3.

Network Structure and Function in Parkinson's Disease.

Ko JH, Spetsieris PG, Eidelberg D.

Cereb Cortex. 2018 Dec 1;28(12):4121-4135. doi: 10.1093/cercor/bhx267.

PMID:
29088324
4.

Metabolic resting-state brain networks in health and disease.

Spetsieris PG, Ko JH, Tang CC, Nazem A, Sako W, Peng S, Ma Y, Dhawan V, Eidelberg D.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2563-8. doi: 10.1073/pnas.1411011112. Epub 2015 Feb 9.

5.

A full-brain, bootstrapped analysis of diffusion tensor imaging robustly differentiates Parkinson disease from healthy controls.

Skidmore FM, Spetsieris PG, Anthony T, Cutter GR, von Deneen KM, Liu Y, White KD, Heilman KM, Myers J, Standaert DG, Lahti AC, Eidelberg D, Ulug AM.

Neuroinformatics. 2015 Jan;13(1):7-18. doi: 10.1007/s12021-014-9222-9.

6.

Quantifying significance of topographical similarities of disease-related brain metabolic patterns.

Ko JH, Spetsieris P, Ma Y, Dhawan V, Eidelberg D.

PLoS One. 2014 Jan 31;9(1):e88119. doi: 10.1371/journal.pone.0088119. eCollection 2014.

7.

Identification of disease-related spatial covariance patterns using neuroimaging data.

Spetsieris P, Ma Y, Peng S, Ko JH, Dhawan V, Tang CC, Eidelberg D.

J Vis Exp. 2013 Jun 26;(76). doi: 10.3791/50319.

8.

Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners.

Peng S, Ma Y, Spetsieris PG, Mattis P, Feigin A, Dhawan V, Eidelberg D.

Hum Brain Mapp. 2014 May;35(5):1801-14. doi: 10.1002/hbm.22295. Epub 2013 May 14.

9.

Parkinson's disease: increased motor network activity in the absence of movement.

Ko JH, Mure H, Tang CC, Ma Y, Dhawan V, Spetsieris P, Eidelberg D.

J Neurosci. 2013 Mar 6;33(10):4540-9. doi: 10.1523/JNEUROSCI.5024-12.2013.

10.

Abnormal network topographies and changes in global activity: absence of a causal relationship.

Dhawan V, Tang CC, Ma Y, Spetsieris P, Eidelberg D.

Neuroimage. 2012 Dec;63(4):1827-32. doi: 10.1016/j.neuroimage.2012.08.039. Epub 2012 Aug 19.

11.

Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Ma Y, Peng S, Spetsieris PG, Sossi V, Eidelberg D, Doudet DJ.

J Cereb Blood Flow Metab. 2012 Apr;32(4):633-42. doi: 10.1038/jcbfm.2011.166. Epub 2011 Nov 30.

12.

Three-fold cross-validation of parkinsonian brain patterns.

Spetsieris PG, Dhawan V, Eidelberg D.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:2906-9. doi: 10.1109/IEMBS.2010.5626327.

PMID:
21095982
13.

Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues.

Spetsieris PG, Eidelberg D.

Neuroimage. 2011 Feb 14;54(4):2899-914. doi: 10.1016/j.neuroimage.2010.10.025. Epub 2010 Oct 20.

14.

Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features.

Spetsieris PG, Ma Y, Dhawan V, Eidelberg D.

Neuroimage. 2009 May 1;45(4):1241-52. doi: 10.1016/j.neuroimage.2008.12.063. Epub 2009 Jan 14.

PMID:
19349238
15.

New strategies for automated differential diagnosis of degenerative brain disorders.

Spetsieris PG, Ma Y, Eckert T, Dhawan V, Eidelberg D.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:3421-5.

PMID:
18002732
16.

Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D.

J Cereb Blood Flow Metab. 2007 Mar;27(3):597-605. Epub 2006 Jun 28.

17.

Microstructural white matter changes in carriers of the DYT1 gene mutation.

Carbon M, Kingsley PB, Su S, Smith GS, Spetsieris P, Bressman S, Eidelberg D.

Ann Neurol. 2004 Aug;56(2):283-6.

PMID:
15293281
18.

Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.

Dhawan V, Ma Y, Pillai V, Spetsieris P, Chaly T, Belakhlef A, Margouleff C, Eidelberg D.

J Nucl Med. 2002 Oct;43(10):1324-30.

19.

Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study.

Ma Y, Dhawan V, Mentis M, Chaly T, Spetsieris PG, Eidelberg D.

Synapse. 2002 Aug;45(2):125-33.

PMID:
12112405
20.

Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.

Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, Spetsieris P, Antonini A, Eidelberg D.

J Nucl Med. 2001 Nov;42(11):1591-5.

21.

Functional brain networks in DYT1 dystonia.

Eidelberg D, Moeller JR, Antonini A, Kazumata K, Nakamura T, Dhawan V, Spetsieris P, deLeon D, Bressman SB, Fahn S.

Ann Neurol. 1998 Sep;44(3):303-12.

PMID:
9749595
22.

The metabolic anatomy of tremor in Parkinson's disease.

Antonini A, Moeller JR, Nakamura T, Spetsieris P, Dhawan V, Eidelberg D.

Neurology. 1998 Sep;51(3):803-10.

PMID:
9748030
23.

Metabolic correlates of pallidal neuronal activity in Parkinson's disease.

Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, Spetsieris P, Alterman R, Kelly PJ, Dogali M, Fazzini E, Beric A.

Brain. 1997 Aug;120 ( Pt 8):1315-24.

PMID:
9278625
24.

The metabolic topography of normal aging.

Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Mandel F, Alexander GE, Grady C, Pietrini P, Eidelberg D.

J Cereb Blood Flow Metab. 1996 May;16(3):385-98.

PMID:
8621743
25.

Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease.

Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Silbersweig D, Stern E, Woods RP, Fazzini E, Dogali M, Beric A.

Ann Neurol. 1996 Apr;39(4):450-9.

PMID:
8619523
26.

Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.

Ishikawa T, Dhawan V, Chaly T, Margouleff C, Robeson W, Dahl JR, Mandel F, Spetsieris P, Eidelberg D.

J Nucl Med. 1996 Feb;37(2):216-22.

27.

The metabolic topography of idiopathic torsion dystonia.

Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Przedborski S, Fahn S.

Brain. 1995 Dec;118 ( Pt 6):1473-84.

PMID:
8595478
28.

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, Belakhlef A, Mandel F, Przedborski S, Fahn S.

Neurology. 1995 Nov;45(11):1995-2004.

PMID:
7501148
29.

Visualizing the evolution of abnormal metabolic networks in the brain using PET.

Spetsieris PG, Moeller JR, Dhawan V, Ishikawa T, Eidelberg D.

Comput Med Imaging Graph. 1995 May-Jun;19(3):295-306.

PMID:
7641174
30.

Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.

Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, Robeson W, Dahl JR, Margouleff D.

J Nucl Med. 1995 Mar;36(3):378-83.

31.

Quantitative brain FDG/PET studies using dynamic aortic imaging.

Dhawan V, Takikawa S, Robeson W, Spetsieris P, Chaly T, Dahl R, Zanzi I, Bandyopadhyay D, Margouleff D, Eidelberg D.

Phys Med Biol. 1994 Sep;39(9):1475-87.

PMID:
15552117
32.

The metabolic topography of parkinsonism.

Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S, et al.

J Cereb Blood Flow Metab. 1994 Sep;14(5):783-801.

PMID:
8063874
33.

Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.

Przedborski S, Giladi N, Takikawa S, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, Fahn S, Eidelberg D.

Neurology. 1994 Sep;44(9):1622-8.

PMID:
7936286
34.

Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations.

Takikawa S, Dhawan V, Chaly T, Robeson W, Dahl R, Zanzi I, Mandel F, Spetsieris P, Eidelberg D.

J Nucl Med. 1994 Jun;35(6):955-63.

35.

Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve.

Takikawa S, Dhawan V, Spetsieris P, Robeson W, Chaly T, Dahl R, Margouleff D, Eidelberg D.

Radiology. 1993 Jul;188(1):131-6.

PMID:
8511286

Supplemental Content

Loading ...
Support Center